KRISTIN ANDERSON: Open Payments
NPI 1568957819 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 13 payments from 9 companies in 2025. Trend: 2023 $27 · 2024 $146 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Novo Nordisk Inc | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| IBSA Pharma Inc. | 1 | $17 |
Products named: CAPLYTA, FARXIGA, Rybelsus, Auvelity, MOUNJARO, JARDIANCE, TRINTELLIX, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
